Vaginal misoprostol for first trimester termination of pregnancy prior to 9 weeks of gestation

ISRCTN ISRCTN18011364
DOI https://doi.org/10.1186/ISRCTN18011364
Secondary identifying numbers 831037
Submission date
14/10/2002
Registration date
14/10/2002
Last edited
02/07/2009
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Pregnancy and Childbirth
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr CSW Ngai
Scientific

Department of Obstetrics and Gynaecology
Faculty of Medicine
University of Hong Kong
-
-
Hong Kong

Study information

Study designRandomised controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Hospital
Study typeTreatment
Scientific title
Study objectivesNot provided at time of registration
Ethics approval(s)Not provided at time of registration
Health condition(s) or problem(s) studiedMedical abortion
InterventionPatients will be randomised into two groups:
1. Group one will be treated using misoprostol with three drops of water (the 'water group')
2. Group two will only use misoprostol (the 'no water group')
Intervention typeDrug
Pharmaceutical study type(s)
PhaseNot Specified
Drug / device / biological / vaccine name(s)Misoprostol
Primary outcome measureNot provided at time of registration
Secondary outcome measuresNot provided at time of registration
Overall study start date01/01/1998
Completion date01/01/2000

Eligibility

Participant type(s)Patient
Age groupAdult
SexFemale
Target number of participants80
Key inclusion criteria1. The duration of menstrual delay is less than 49 days
2. The size of the uterus on pelvic examination is compatible with the estimated duration of pregnancy
3. A positive pregnancy test
4. There is no history of significant medical illness
5. Age greater than 16 years old
6. Requests legal termination of pregnancy
Key exclusion criteria1. History or evidence of disorders that represent a contraindication to the use of misoprostol (mitral stenosis, glaucoma, sickle cell anaemia, diastolic pressure >100 mm Hg, bronchial asthma)
2. History or evidence of thrombo-embolism, severe or recurrent liver disease or pruritus of pregnancy
3. Presence of intrauterine contraceptive device (IUCD) in utero
4. Suspect or proven ectopic pregnancy
5. Heavy smoker (smoking >10 cigarettes daily in the past 2 years) or had another risk factor for cardiovascular disease
Date of first enrolment01/01/1998
Date of final enrolment01/01/2000

Locations

Countries of recruitment

  • Hong Kong

Study participating centre

Department of Obstetrics and Gynaecology
-
-
Hong Kong

Sponsor information

Hong Kong Health Services Research Fund (Hong Kong)
Government

Health Welfare and Food Bureau
Government Secretariat, HKSAR
20th floor Murray Building
Garden Road
-
-
Hong Kong

Phone +852 (0)2973 8288
Email hsrf@hwfb.gov.hk
Website http://www.fhb.gov.hk/grants/english/funds/funds_hhsrf/funds_hhsrf_abt/funds_hhsrf_abt.html
ROR logo "ROR" https://ror.org/03qh32912

Funders

Funder type

Government

Hong Kong Health Services Research Fund (Hong Kong)

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 01/05/2000 Yes No